{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:13:51Z","timestamp":1772190831477,"version":"3.50.1"},"reference-count":36,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2026,1,5]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>Pain is one of the most distressing symptoms that patients experience as they approach the end of life. Opioids remain the gold standard of care, but the need for alternative options continues to grow, especially in the face of opioid unresponsive pain or opioid side effects. Clonidine, a drug initially known as a nasal decongestant and anti-hypertensive, has shown promise through its depression of the sympathetic nervous system by inhibiting norepinephrine release. It has since shown potential as an analgesic post-operatively, helping to reduce overall opioid use while providing adequate pain relief. This systematic review aimed to collate and analyse the available literature on the use of clonidine as an analgesic for palliative care patients. A comprehensive literature search was performed on CENTRAL, SCOPUS, MEDLINE, EMBASE and ClinicalTrials.gov for studies assessing the use of clonidine as analgesia for patients under palliative care. Twelve studies involving 194 patients were included. All studies were either case reports or case series. Clonidine was used as both monotherapy and as an adjunct through a variety of delivery methods, including intrathecal, perineural, subcutaneous and transdermal. Clonidine has shown initial potential to provide adequate analgesia while reducing overall opioid usage. However, further research is required to form a stronger evidence base and gain further insight into its future role in this field. Further insight is also required into more easily accessible delivery, such as oral, subcutaneous and transdermal routes.<\/jats:p>","DOI":"10.1136\/spcare-2025-006003","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:20:18Z","timestamp":1769106018000},"page":"288-296","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Clonidine as an Analgesic in Adult Palliative Care: Efficacy and Safety\u2013Systematic Review"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7013-3570","authenticated-orcid":false,"given":"Jasen","family":"Soopramanien","sequence":"first","affiliation":[{"name":"University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshya","family":"Soni","sequence":"additional","affiliation":[{"name":"Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samiyah","family":"Saghir","sequence":"additional","affiliation":[{"name":"Nottingham University Hospitals NHS Trust, Nottingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeevtesh","family":"Soni","sequence":"additional","affiliation":[{"name":"Medway NHS Foundation Trust, Gillingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagar","family":"Mittal","sequence":"additional","affiliation":[{"name":"Edge Hill University, Ormskirk, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Papia","family":"Sarker","sequence":"additional","affiliation":[{"name":"Hayward House, Nottingham University Hospitals NHS Trust, Nottingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"2026022702201312000_16.2.288.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2016.01.135"},{"key":"2026022702201312000_16.2.288.2","unstructured":"Zamora B , Cookson G , Garau M . Unrelieved pain in palliative care in England. London Office of Health Economics: OHE Consulting Report."},{"key":"2026022702201312000_16.2.288.3","first-page":"93","article-title":"WHO guidelines for the use of analgesics in cancer pain","volume":"7","author":"Ventafridda","year":"1985","journal-title":"Int J Tissue React"},{"key":"2026022702201312000_16.2.288.4","first-page":"695","article-title":"Use of non-opioid analgesics as adjuvants to opioid analgesia for cancer pain management in an inpatient palliative unit: does this improve pain control and reduce opioid requirements?","volume":"23","author":"Shinde","year":"2015","journal-title":"Support Care Cancer"},{"key":"2026022702201312000_16.2.288.5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1053\/bean.2000.0079","article-title":"A historical perspective: development of clonidine","volume":"14","author":"St\u00e4hle","year":"2000","journal-title":"Best Practice & Research Clinical Anaesthesiology"},{"key":"2026022702201312000_16.2.288.6","doi-asserted-by":"publisher","DOI":"10.1007\/BF00609752"},{"key":"2026022702201312000_16.2.288.7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1525-1403.1999.00085.x","article-title":"Alternative Intrathecal Agents for the Treatment of Pain","volume":"2","author":"Hassenbusch","year":"1999","journal-title":"Neuromodulation: Technology at the Neural Interface"},{"key":"2026022702201312000_16.2.288.8","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-001-0038-6"},{"key":"2026022702201312000_16.2.288.9","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.9-5-571"},{"key":"2026022702201312000_16.2.288.10","doi-asserted-by":"publisher","DOI":"10.1136\/spcare-2022-003651"},{"key":"2026022702201312000_16.2.288.11","doi-asserted-by":"crossref","unstructured":"Aromataris E , Lockwood C , Porritt K , et al , eds. JBI manual for evidence synthesis. JBI, 2024. Available: https:\/\/jbi-global-wiki.refined.site\/space\/MANUAL","DOI":"10.46658\/JBIMES-24-01"},{"key":"2026022702201312000_16.2.288.12","doi-asserted-by":"crossref","unstructured":"Munn Z , Barker TH , Moola S , et al . Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Database Syst Rev Implement Rep 2019. doi:10.11124\/JBISRIR-D-19-00099","DOI":"10.11124\/JBISRIR-D-19-00099"},{"key":"2026022702201312000_16.2.288.13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.thromres.2023.05.020","article-title":"Idarucizumab for dabigatran reversal: A systematic review and meta-analysis of indications and outcomes","volume":"228","author":"van der Horst","year":"2023","journal-title":"Thromb Res"},{"key":"2026022702201312000_16.2.288.14","doi-asserted-by":"publisher","DOI":"10.1136\/spcare-2024-004872"},{"key":"2026022702201312000_16.2.288.15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00000542-198503000-00028","article-title":"Intrathecal morphine tolerance: use of intrathecal clonidine, DADLE, and intraventricular morphine","volume":"62","author":"Coombs","year":"1985","journal-title":"Anesthesiology"},{"key":"2026022702201312000_16.2.288.16","first-page":"599","article-title":"Dialogues on complex analgesic strategies for difficult pain syndromes","volume":"12","author":"Mercadante","year":"2004","journal-title":"Support Care Cancer"},{"key":"2026022702201312000_16.2.288.17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/0310057X1003800324","article-title":"Continuous Tunnelled Femoral Nerve Block for Palliative Care of a Patient with Metastatic Osteosarcoma","volume":"38","author":"Pacenta","year":"2010","journal-title":"Anaesth Intensive Care"},{"key":"2026022702201312000_16.2.288.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(98)00133-X"},{"key":"2026022702201312000_16.2.288.19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1155\/2015\/405630","article-title":"Efficacy of an intrathecal multidrug infusion for pain control in older adults and in end-stage malignancies: A report of three cases","volume":"20","author":"Abdolmohammadi","year":"2015","journal-title":"Pain Res Manag"},{"key":"2026022702201312000_16.2.288.20","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000086725.01761.8B"},{"key":"2026022702201312000_16.2.288.21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0885-3924(00)00226-8","article-title":"Opioid Nonresponsiveness in Cancer Pain Can Be Reversible. A Serendipitous Conclusion of a Retrospective Analysis","volume":"20","author":"Arcuri","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"2026022702201312000_16.2.288.22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/082585970301900411","article-title":"Case study report of two palliative care patients receiving intracerebroventricular (ICV) analgesia","volume":"19","author":"Vojkovic","year":"2003","journal-title":"J Palliat Care"},{"key":"2026022702201312000_16.2.288.23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.sjpain.2016.10.002","article-title":"Multimodal intrathecal analgesia in refractory cancer pain","volume":"14","author":"Mastenbroek","year":"2017","journal-title":"Scand J Pain"},{"key":"2026022702201312000_16.2.288.24","doi-asserted-by":"crossref","unstructured":"Bosco D . Length of Stay: To the Infinityand beyond. Reg Anesth Pain Med 2012;37. doi:10.1097\/AAP.0b013e31826a8366","DOI":"10.1097\/AAP.0b013e31826a8366"},{"key":"2026022702201312000_16.2.288.25","doi-asserted-by":"crossref","unstructured":"Serednicki WT , Wrzosek A , Woron J , et al . Topical clonidine for neuropathic pain in adults. Cochrane Database of Systematic Reviews 2022;2022. doi:10.1002\/14651858.CD010967.pub3","DOI":"10.1002\/14651858.CD010967.pub3"},{"key":"2026022702201312000_16.2.288.26","doi-asserted-by":"crossref","unstructured":"Wiffen PJ , Wee B , Derry S , et al . Opioids for cancer pain - an overview of cochrane reviews. cochrane pain, palliative and supportive care group, editor. In: The Cochrane database of systematic reviews. 2020. Available: http:\/\/doi.wiley.com\/10.1002\/14651858.CD012592.pub2","DOI":"10.1002\/14651858.CD012592.pub2"},{"key":"2026022702201312000_16.2.288.27","unstructured":"Schmidt-Hansen M , Bennett MI , Arnold S , et al . Oxycodone for cancer-related pain. cochrane pain, palliative and supportive care group, editor. In: The Cochrane database of systematic reviews. Available: http:\/\/doi.wiley.com\/10.1002\/14651858.CD003870.pub6"},{"key":"2026022702201312000_16.2.288.28","doi-asserted-by":"crossref","unstructured":"Els C , Jackson TD , Kunyk D , et al . Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews. Cochrane Database Syst Rev 2018;2018. doi:10.1002\/14651858.CD012509.pub2","DOI":"10.1002\/14651858.CD012509.pub2"},{"key":"2026022702201312000_16.2.288.29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/papr.12111","article-title":"Intrathecal drug administration in chronic pain syndromes","volume":"14","author":"Ver Donck","year":"2014","journal-title":"Pain Pract"},{"key":"2026022702201312000_16.2.288.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(03)00144-1"},{"key":"2026022702201312000_16.2.288.31","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(92)90201-L"},{"key":"2026022702201312000_16.2.288.32","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-200012000-00037"},{"key":"2026022702201312000_16.2.288.33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0022-3565(24)38100-5","article-title":"Response Surface Analysis of Synergism Between Morphine and Clonidine","volume":"289","author":"Tallarida","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"2026022702201312000_16.2.288.34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/bcpt.13979","article-title":"Review of clinical pharmacokinetics and pharmacodynamics of clonidine as an adjunct to opioids in palliative care","volume":"134","author":"Amna","year":"2024","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2026022702201312000_16.2.288.35","doi-asserted-by":"crossref","unstructured":"Porchet HC , Piletta P , Dayer P . Pharmacokinetic-pharmacodynamic modeling of the effects of clonidine on pain threshold, blood pressure, and salivary flow. Eur J Clin Pharmacol 1992;42. doi:10.1007\/BF00265932","DOI":"10.1007\/BF00265932"},{"key":"2026022702201312000_16.2.288.36","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aes344"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2025-006003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T10:22:03Z","timestamp":1772187723000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2025-006003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,27]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/spcare-2025-006003"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2025-006003","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]}}}